Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

4.35
Delayed Data
As of Aug 18
 -0.05 / -1.14%
Today’s Change
3.66
Today|||52-Week Range
6.64
-5.43%
Year-to-Date

Today’s Trading

Previous close4.40
Today’s open4.34
Day’s range4.31 - 4.44
Volume140,130
Average volume (3 months)239,090
Market cap$204.7M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+38.20%
Earnings growth (this year)-1.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.02%
P/E ratioNM
Price/Sales37.33
Price/Book0.73

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp-0.20-2.45%
CKPTCheckpoint Therapeut...-0.25-3.03%
ALBOAlbireo Pharma Inc+0.11+0.47%
ABUSArbutus Biopharma Co...0.000.00%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$5.7M
Annual profit (last year)-$76.4M
Net profit margin-1,339.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts